These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11828325)

  • 1. Structural basis for CDK6 activation by a virus-encoded cyclin.
    Schulze-Gahmen U; Kim SH
    Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
    Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
    Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
    Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
    J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of a complex between human CDK6 and a virus-encoded cyclin is critically dependent on the addition of small charged organic molecules.
    Schulze-Gahmen U; Kim SH
    Acta Crystallogr D Biol Crystallogr; 2001 Sep; 57(Pt 9):1287-9. PubMed ID: 11526321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.
    Ojala PM; Yamamoto K; Castaños-Vélez E; Biberfeld P; Korsmeyer SJ; Mäkelä TP
    Nat Cell Biol; 2000 Nov; 2(11):819-25. PubMed ID: 11056537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
    Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
    EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6.
    Ojala PM; Tiainen M; Salven P; Veikkola T; Castaños-Vélez E; Sarid R; Biberfeld P; Mäkelä TP
    Cancer Res; 1999 Oct; 59(19):4984-9. PubMed ID: 10519412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
    Park H; Yeom MS; Lee S
    Chembiochem; 2004 Dec; 5(12):1662-72. PubMed ID: 15505811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of cyclin-dependent kinase activation by phosphorylation.
    Russo AA; Jeffrey PD; Pavletich NP
    Nat Struct Biol; 1996 Aug; 3(8):696-700. PubMed ID: 8756328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence.
    Child ES; Mann DJ
    Oncogene; 2001 Jun; 20(26):3311-22. PubMed ID: 11423981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
    Kwon TK; Park JW
    Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.